Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 246

ORDER re Hearings on Summary Judgment Motions. Signed by Judge Joseph C. Spero on January 25, 2013. (jcslc1, COURT STAFF) (Filed on 1/25/2013)

1
2
3

UNITED STATES DISTRICT COURT

4

NORTHERN DISTRICT OF CALIFORNIA

5
6
7

TAKEDA PHARMACEUTICAL CO., LTD, et

8

al.,

Related Cases: C-11-01609, C-11-01610
Plaintiff,

9

v.

10

United States District Court
Northern District of California

11

HANDA PHARMACEUTICALS, LLC, et al.,
Defendant.

12
13
14
15

TAKEDA PHARMACEUTICAL CO., LTD.,

16

et al.,

17
18

Plaintiff,
v.

19

ANCHEN PHARMACEUTICALS, INC.,

20

AND TWI PHARMACEUTICALS, INC.,

21

Defendants.

22

TAKEDA PHARMACEUTICAL CO., LTD.,

23

ET AL.,

24
25
26
27
28

Case No.: 11-00840 JCS

Plaintiffs,
v.
IMPAX LABORATORIES, INC.,
Defendant.

ORDER RE HEARINGS ON SUMMARY
JUDGMENT MOTIONS

1

Currently pending before the Court are six summary judgment motions, which the Court

2

set for hearing on February 8, 2013 at 9:30 a.m. Having reviewed the parties’ submissions, the

3

Court concludes that in order to adequately address the issues raised in the motions, it will be

4

necessary to set an additional hearing, which shall be held on February 22, 2013 at 2:00 p.m.

5

The Court will reserve two hours for each hearing. At the February 8, 2013 hearing, the Court

6

intends to address: 1) infringement of the ‘282 patent, including the existence of subject matter

7

jurisdiction over Takeda’s infringement claims based on that patent; 2) infringement of the ‘276

8

patent; 3) infringement of the ‘755 patent; and 4) invalidity based on indefiniteness of the asserted

9

claims of the ‘755 patent. At the February 22, 2013 hearing, the Court intends to address: 1)
invalidity based on anticipation of the asserted claims of the ‘282 patent; 2) invalidity based on

11

United States District Court
Northern District of California

10

lack of written description supporting the asserted claims of the ‘282 patent; 3) infringement of

12

the ‘058 patent; and 4) infringement and invalidity of the ‘971 patent.

13
14

IT IS SO ORDERED.
Dated: January 25, 2013

15

________________________
Joseph C. Spero
United States Magistrate Judge

16
17
18
19
20
21
22
23
24
25
26
27
28

2